BI 695501: Clinical Trials

6 trials of BI 695501, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 5 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 11Completed 1

Follow BI 695501: new trials by email Literature Review of BI 695501 trials Research Report on BI 695501

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
Humira®, BI 695501 - Psoriasis
Phase 3CompletedBoehringer Ingelheim2592017-07-102021-07-14
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
BI 695501, HUMIRA - Crohn Disease
Phase 3CompletedBoehringer Ingelheim1472016-09-282020-06-04
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
BI 695501, Humira - Psoriasis
Phase 3CompletedBoehringer Ingelheim3182016-08-172019-02-08
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
BI 695501 - Arthritis, Rheumatoid
Phase 3CompletedBoehringer Ingelheim4302016-01-222018-12-05
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
BI 695501, US-licensed Humira® - Arthritis, Rheumatoid
Phase 3CompletedBoehringer Ingelheim6452015-01-262018-01-19
Pharmacokinetics and Safety in Healthy Volunteers
BI 695501, adalimumab-EU source, adalimumab-US source - Healthy
Phase 1CompletedBoehringer Ingelheim3272014-01-312018-06-20

Conditions studied

Arthritis, Rheumatoid (2)  ·  Psoriasis (2)  ·  Crohn Disease (1)

Sponsors

Boehringer Ingelheim (6)

Countries

Germany (5)  ·  Poland (5)  ·  Russia (5)  ·  Ukraine (5)  ·  United States (5)  ·  Estonia (3)  ·  Hungary (3)  ·  Serbia (3)  ·  Bulgaria (2)  ·  Chile (2)  ·  Czechia (2)  ·  Malaysia (2)  ·  New Zealand (2)  ·  South Korea (2)  ·  Spain (2)

Results publications

PMID 32363771, PMID 33263165, PMID 39551590, PMID 40498294, PMID 27813422, PMID 29514803, PMID 31387417, PMID 33317345, PMID 34388360, PMID 35934770, PMID 36065786, PMID 36511191, PMID 39120847

NIH funding

2016 (3), 2015 (1)